Todd Korthuis, M.D., M.P.H., and Atheir Abbas, M.D., Ph.D., are appointed to Gov. Kate Brown’s Oregon Psilocybin Advisory Committee, which will help to develop a science-based framework for safe and effective use of psilocybin in alignment with the passage of Measure 109.

Mark Miller, D.M.D., describes how Oregon dentists are contributing to the state’s COVID-19 vaccination efforts and how OHSU is providing vaccination training for dentists statewide.

An online auction of special-edition Air Jordan 1 sneakers raises $1.1 million for OHSU Doernbecher Children’s Hospital.

OHSU will continue to monitor and support the 111 local people who enrolled in the AstraZeneca COVID-19 vaccine trial at OHSU.

Marcel Curlin, M.D., states that OHSU is not aware of any blood-clotting issues behind discovered among the 111 local individuals who enrolled in the AstraZeneca trial through OHSU.

Kent Thornburg, Ph.D., will present on how food we eat today can impact the health of future generations during an April 24 webinar.

The Kuni Foundation awarded OHSU $2.5 million to develop low-cost blood biopsies for early cancer detection in underserved communities and to expand the Knight Scholar Program.

In a story about some European countries pausing their use of the AstraZeneca vaccine after some people who have received it later had blood-clotting issues, Mark Slifka, Ph.D., says “There are a lot of causes of blood clotting, a lot of predisposing factors, and a lot of people who are at increased risk – and these are often also the people who are being vaccinated right now.”

Juan Piantino, M.D., MCR led a study that found sound sleep plays a critical role in healing traumatic brain injuries.

Retired teacher Rick Barde was discharged from OHSU March 12 after two months of hospitalization, including two weeks on ECMO life support.